Matthew Oberholzer

Matthew Oberholzer is a seasoned chemical engineer with extensive experience in process development, scale-up, and technical leadership across various sectors including pharmaceuticals and agriculture. They have a notable track record of successful projects, including the development of rynaxypyr® and cyazypyr® insecticides, as well as the active pharmaceutical ingredient for apixaban, marketed as Eliquis®. Currently, Matthew serves as the A.I. Synthesis Process Engineering and Technical Manager at Gowan Company while also operating as the Principal Consultant for GO3O, LLC, where they drive R&D and scale-up efforts for multiple industries. They earned a PhD in Chemical Engineering from the University of Delaware and have contributed to academia as an adjunct professor.